Home Compare BMY vs FFIV
Stock Comparison · Cheaper and stronger

Bristol-Myers Squibb Company vs F5: Which Stock Looks Stronger in 2026?

Bristol-Myers Squibb Company holds the cleaner structural position, with the lead spread across valuation and growth. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.

Updated 2026-08-16

This is not just a one-metric split: both valuation and growth materially support the lead. The overall score gap is 11 points in favour of Bristol-Myers Squibb Company.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #10
within Bristol-Myers Squibb Company's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in revenue stability and investment intensity.

Similarity drivers
revenue stabilityinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BMY
Bristol-Myers Squibb Company
62
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
FFIV
F5, Inc.
51
Peer-Score
Signal qualitylow
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing and operating quality both support the lead here.

Dimension spread: BMY vs FFIV Profitability 40 47 Stability 58 64 Valuation 84 56 Growth 64 39 BMY FFIV
Gap Ranking
#1 Valuation +28
#2 Growth +25
#3 Profitability +7
#4 Stability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMY and FFIV Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMYFFIV Relative valuation Structural strength

Bristol-Myers Squibb Company and F5, Inc. look relatively close on structure, but the price setup still leans toward Bristol-Myers Squibb Company.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where BMY and FFIV each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY BMY Elevated · above norm 0th 50th 100th 4 pct gap FFIV Elevated · above norm 0th 50th 100th 95th 99th
BMY (95th percentile) and FFIV (99th percentile) both sit in the upper portion of their own 5-year ranges. The historical entry context is broadly similar for both. This reflects entry timing, not which company is structurally stronger.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Valuation
Both rank well on valuation, but Bristol-Myers Squibb Company still holds a clear edge.
Growth
Bristol-Myers Squibb Company sits in the stronger part of the group on growth, while F5, Inc. is closer to mid-pack.
Valuation — Dominant Gap
BMY
84
FFIV
56
Gap+28in favour of BMY

The multiple-based pricing edge comes from a forward P/E that is 12.6 turns lower.

What else supports the lead

Earnings growth is one contributing factor within the growth lead.

What this means for the comparison

The lead is built on both valuation and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the BMY vs FFIV comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-growth comparisons

Explore how BMY and FFIV each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.